Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 111, Issue 1, Pages 24-30Publisher
WILEY-BLACKWELL
DOI: 10.1002/jso.23778
Keywords
genetic testing; diagnostic genomics; thyroid cancer; Burkitt's lymphoma; gastrointestinal stromal tumors
Ask authors/readers for more resources
Genomic diagnostics in cancer has evolved since the completion of the Human Genome Project and the advancements made in diagnosis and therapy in chronic myelogenous leukemia. Among the diseases to achieve limited success or potentially benefit from diagnostic genetic testing are thyroid cancer, Burkitt's lymphoma, gastrointestinal stromal tumors, adrenocortical carcinoma, and colorectal cancer. With increased understanding of genomics, genetic tests should improve diagnosis and help guide medical and surgical management. J. Surg. Oncol. 2015 111:24-30. (c) 2014 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available